Tuberculosis prevention must integrate technological and basic care innovation

Affiliations

¹ Foundation for Innovative New Diagnostics, Cape Town, South Africa heidi.albert@finddx.org.
² Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
³ Foundation for Innovative New Diagnostics, Geneva, Switzerland.

Free article

Comment

Heidi Albert et al. Eur Respir J. 2016 Nov.

Free article

. 2016 Nov;48(5):1531-1532.

doi: 10.1183/13993003.01601-2016.

¹ Foundation for Innovative New Diagnostics, Cape Town, South Africa heidi.albert@finddx.org.
² Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
³ Foundation for Innovative New Diagnostics, Geneva, Switzerland.

No abstract available

Comment on

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?
Albert H, Nathavitharana RR, Isaacs C, Pai M, Denkinger CM, Boehme CC. Albert H, et al. Eur Respir J. 2016 Aug;48(2):516-25. doi: 10.1183/13993003.00543-2016. Epub 2016 Jul 13. Eur Respir J. 2016. PMID: 27418550 Free PMC article. Review.
Tuberculosis prevention must integrate technological and basic care innovation.
Mason PH, Oni T, van Herpen MM, Coussens AK. Mason PH, et al. Eur Respir J. 2016 Nov;48(5):1529-1531. doi: 10.1183/13993003.01449-2016. Eur Respir J. 2016. PMID: 27799402 Free PMC article.